412 related articles for article (PubMed ID: 11426990)
1. Metastatic serous borderline ovarian tumor in an internal mammary lymph node: a case report and review of the literature.
Chamberlin MD; Eltabbakh GH; Mount SL; Leavitt BJ
Gynecol Oncol; 2001 Jul; 82(1):212-5. PubMed ID: 11426990
[TBL] [Abstract][Full Text] [Related]
2. Possible metaplastic origin of lymph node "metastases" in serous ovarian tumor of low malignant potential (borderline serous tumor).
Kadar N; Krumerman M
Gynecol Oncol; 1995 Dec; 59(3):394-7. PubMed ID: 8522262
[TBL] [Abstract][Full Text] [Related]
3. Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors.
Takeshima N; Hirai Y; Umayahara K; Fujiwara K; Takizawa K; Hasumi K
Gynecol Oncol; 2005 Nov; 99(2):427-31. PubMed ID: 16112718
[TBL] [Abstract][Full Text] [Related]
4. Müllerian and mesothelial lymph node involvement in patients with borderline ovarian tumors.
Eltabbakh GH; Mount SL
J Reprod Med; 2011; 56(5-6):211-8. PubMed ID: 21682116
[TBL] [Abstract][Full Text] [Related]
5. Lymph node metastasis in stage I epithelial ovarian cancer.
Suzuki M; Ohwada M; Yamada T; Kohno T; Sekiguchi I; Sato I
Gynecol Oncol; 2000 Nov; 79(2):305-8. PubMed ID: 11063662
[TBL] [Abstract][Full Text] [Related]
6. [Benign epithelial inclusions in pelvic lymph nodes. 2 case reports].
Alvarado Cabrero I; Sosa Romero A
Ginecol Obstet Mex; 2000 Feb; 68():77-81. PubMed ID: 10774109
[TBL] [Abstract][Full Text] [Related]
7. Hyperplastic mesothelial cells within abdominal lymph nodes: mimic of metastatic ovarian carcinoma and serous borderline tumor--a report of two cases associated with ovarian neoplasms.
Clement PB; Young RH; Oliva E; Sumner HW; Scully RE
Mod Pathol; 1996 Sep; 9(9):879-86. PubMed ID: 8878019
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetic evidence of an independent origin of serous low malignant potential implants and lymph node inclusions.
Emerson RE; Wang M; Liu F; Lawrence WD; Abdul-Karim FW; Cheng L
Int J Gynecol Pathol; 2007 Oct; 26(4):387-94. PubMed ID: 17885488
[TBL] [Abstract][Full Text] [Related]
9. Pelvic and aortic lymph node metastasis in epithelial ovarian cancer.
Pereira A; Magrina JF; Rey V; Cortes M; Magtibay PM
Gynecol Oncol; 2007 Jun; 105(3):604-8. PubMed ID: 17321572
[TBL] [Abstract][Full Text] [Related]
10. Borderline tumor of the lymph node associated with bilateral serous borderline tumor of the ovary: case report.
Tulunay G; Baykal C; Cil A; Kahraman B; Ozer S; Cavuşoğlu D
Eur J Gynaecol Oncol; 2004; 25(5):632-4. PubMed ID: 15493184
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of lymph node involvement in ovarian serous borderline tumors.
Lesieur B; Kane A; Duvillard P; Gouy S; Pautier P; Lhommé C; Morice P; Uzan C
Am J Obstet Gynecol; 2011 May; 204(5):438.e1-7. PubMed ID: 21349494
[TBL] [Abstract][Full Text] [Related]
12. Benign müllerian inclusions in pelvic and paraaortic lymph nodes.
Reich O; Tamussino K; Haas J; Winter R
Gynecol Oncol; 2000 Aug; 78(2):242-4. PubMed ID: 10926810
[TBL] [Abstract][Full Text] [Related]
13. Micropapillary pattern in serous borderline ovarian tumors: does it matter?
Park JY; Kim DY; Kim JH; Kim YM; Kim KR; Kim YT; Nam JH
Gynecol Oncol; 2011 Dec; 123(3):511-6. PubMed ID: 21917305
[TBL] [Abstract][Full Text] [Related]
14. Lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors): pathology, prognosis, and proposed classification.
McKenney JK; Balzer BL; Longacre TA
Am J Surg Pathol; 2006 May; 30(5):614-24. PubMed ID: 16699316
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer.
Negishi H; Takeda M; Fujimoto T; Todo Y; Ebina Y; Watari H; Yamamoto R; Minakami H; Sakuragi N
Gynecol Oncol; 2004 Jul; 94(1):161-6. PubMed ID: 15262135
[TBL] [Abstract][Full Text] [Related]
16. Lymphatic spread among women with primary peritoneal carcinoma.
Eltabbakh GH; Mount SL
J Surg Oncol; 2002 Nov; 81(3):126-31. PubMed ID: 12407724
[TBL] [Abstract][Full Text] [Related]
17. [Risk factors for retroperitoneal lymph node metastasis in ovarian cancer].
Akiyama M; Takahashi Y; Hirose M; Yamamoto Y; Ishiguro T; Noda Y
Nihon Sanka Fujinka Gakkai Zasshi; 1994 Mar; 46(3):260-4. PubMed ID: 8133137
[TBL] [Abstract][Full Text] [Related]
18. Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications.
Morice P; Joulie F; Camatte S; Atallah D; Rouzier R; Pautier P; Pomel C; Lhommé C; Duvillard P; Castaigne D
J Am Coll Surg; 2003 Aug; 197(2):198-205. PubMed ID: 12892797
[TBL] [Abstract][Full Text] [Related]
19. Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary.
Abu-Rustum NR; Restivo A; Ivy J; Soslow R; Sabbatini P; Sonoda Y; Barakat RR; Chi DS
Gynecol Oncol; 2006 Oct; 103(1):31-4. PubMed ID: 16537089
[TBL] [Abstract][Full Text] [Related]
20. Recent developments on the significance and pathogenesis of lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors).
Fadare O
Int J Gynecol Cancer; 2009 Jan; 19(1):103-8. PubMed ID: 19258950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]